Procter & Gamble Health Limited reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was INR 3,099.7 million compared to INR 2,779 million a year ago. Revenue was INR 3,145.1 million compared to INR 2,826 million a year ago. Net income was INR 768 million compared to INR 448.4 million a year ago. Basic earnings per share from continuing operations was INR 46.3 compared to INR 27 a year ago.
For the six months, sales was INR 6,075.2 million compared to INR 5,507 million a year ago. Revenue was INR 6,154.8 million compared to INR 5,584.4 million a year ago. Net income was INR 1,404.6 million compared to INR 1,002.1 million a year ago. Basic earnings per share from continuing operations was INR 84.6 compared to INR 60.4 a year ago.